Crowdonomics
All companies
NEXTLEAP COLD SORE CARE logo

NEXTLEAP COLD SORE CARE

Operating

SkinStasis LLC

Healthcare · Founded 2022

Breakthrough treatment for cold sores-return to normal in 1-2 days

Valuation cap ⓘ
$1.2M
As of Apr 2024 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$106,800
Across 1 round since 2024

Financials

FY2021–FY2024 · from SEC filings · hover any figure for its source
$0
2021
$753
−$78K
2022
$33K
−$139K
2023
$60K
−$227K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 reviewed
FY2022 reviewed
FY2023 unaudited
FY2024 unaudited
Income statement
Revenue
$0
$753
$32,575
$59,544
Cost of goods sold
$0
$84
$4,292
$7,847
Gross margin
—
89%
87%
87%
Net income
$0
-$78,378
-$139,429
-$227,072
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$16,118
$3,272
$40,511
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$84,384
$109,498
$157,482
Short-term debt
$0
$161,762
$1,262
$126,318
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$161,762
$1,262
$126,318
Other
Headcount
—
0
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$1.2M
Valuation cap
Reg CF · Note · Jan 2024

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Raised $106.8K / $1.2MInvestors 26Valuation cap $1.2M

Team

2 people
Frank Murdock
Principal
William Paul Stewart
Principal

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 3 annual reports (FY2023–FY2025)

26 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 18, 20250001670254-25-000380
    EDGAR
  • Form CFeb 2, 20240001670254-24-000096
    EDGAR
Source: ManualCIK 0002009974

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.